2023-2024

◎2024年度はこちら
◎2025年度はこちら

1. Hiono T, Sakaue H, Tomioka A, Kaji H, Sasaki M, Orba Y, Sawa H, Kuno A. “Combinatorial Approach with Mass Spectrometry and Lectin Microarray Dissected Site-Specific Glycostem and Glycoleaf Features of the Virion-Derived Spike Protein of Ancestral and γ Variant SARS-CoV-2 Strains”
   J Proteome Res.,23(4),1408-1419,Epub 2024 Mar 27.(2024 Mar 27), 
   DOI: 10.1021/acs.jproteome.3c00874
2. S Ariizumi T, Tabata K, Itakura Y, Kobayashi H, Hall WW, Sasaki M, Sawa H, Matsuno K, Orba Y. “Establishment of a lethal mouse model of emerging tick-borne orthonairovirus infections”
   PLoS Pathog.,20(3),e1012101,(2024 Mar 19),
   DOI: 10.1371/journal.ppat.1012101
3. Chileshe C, Shawa M, Phiri N, Ndebe J, Khumalo CS, Nakajima C, Kajihara M, Higashi H, Sawa H, Suzuki Y, Muleya W, Hang’ombe BM.”Detection of Extended-Spectrum Beta-Lactamase (ESBL) producing Enterobacteriaceae from diseased broiler chickens in Lusaka district, Zambia.”
   Antibiotics (Basel).,13(3),259,(2024 Mar 15)
   DOI: 10.3390/antibiotics13030259
4. Handabile C, Ohno M, Sekiya T, Nomura N, Kawakita T, Kawahara M, Endo M, Nishimura T, Okumura N, Toba S, Sasaki M, Orba Y, Chua BY, Rowntree LC, Nguyen THO, Shingai M, Sato A, Sawa H, Ogasawara K, Kedzierska K, Kida H.”Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine”
   Sci Rep.,14(1),4204,(2024 Feb 20)
   DOI: 10.1038/s41598-024-54421-1
5. Becken BA, Lamson DM, Gonzalez G, Patel S, St George K, Kajon AE. “A Fulminant Case of Adenovirus Genotype C108 Infection in a Pediatric Stem Cell Transplant Recipient with x-Linked Lymphoproliferative Syndrome Type 1”
   Viruses.,16(1),137,(2024 Jan 18)
   DOI: 10.3390/v16010137
6. Sasaki M, Sugi T, Iida S, Hirata Y, Kusakabe S, Konishi K, Itakura Y, Tabata K, Kishimoto M, Kobayashi H, Ariizumi T, Intaruck K, Nobori H, Toba S, Sato A, Matsuno K, Yamagishi J, Suzuki T, Hall W W, Orba Y, Sawa H. “Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model”
   EBioMedicine.,99,104950,(2023 Dec 30),Epub 2023 Dec 30.
   DOI: 10.1016/j.ebiom.2023.104950
7. Tsumita T, Takeda R, Maishi N, Hida Y, Sasaki M, Orba Y, Sato A, Toba S, Ito W, Teshirogi T, Sakurai Y, Iba T, Naito H, Ando H, Watanabe H, Mizuno A, Nakanishi T, Matsuda A, Zixiao R, Lee Ji-Won, Iimura T, Sawa H, Hida K. “Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models”
   Aging Cell.,23(2),e14050,(2023 Dec 14),Epub 2023 Dec 14.
   DOI:10.1111/acel.14050
8. Orba Y, Abu YE, Chambaro HM, Lundu T, Muleya W, Eshita Y, Qiu Y, Harima H, Kajihara M, Mori-Kajihara A, Matsuno K, Sasaki M, Hall WW, Hang’ombe BM, Sawa H. “Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case”
   Sci Rep.,13(1),18165,(2023 Oct 24)
   DOI: 10.1038/s41598-023-45443-2
9. Fujita S, Uriu K, Pan L, Nao N, Tabata K, Kishimoto M, Itakura Y, Sawa H, Kida I, Tamura T; Genotype to Phenotype Japan (G2P-Japan) Consortium; Fukuhara T, Ito J, Matsuno K, Sato K. “Impact of Imprinted Immunity Induced by mRNA Vaccination in an Experimental Animal Model”
   J Infect Dis., 228(8),1060-1065,(2023 Oct 18)
   DOI: 10.1093/infdis/jiad230
10. Uemura K, Nobori H, Sato A, Toba S, Kusakabe S, Sasaki M, Tabata K, Matsuno K, Maeda N, Ito S, Tanaka M, Anraku Y, Kita S, Ishii M, Kanamitsu K, Orba Y, Matsuura Y, Hall WW, Sawa H, Kida H, Matsuda A, Maenaka K. “2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses”
    Proc Natl Acad Sci U S A., 120(42),e2304139120,(2023 Oct 17)
    DOI: 10.1073/pnas.2304139120
11. Tabata K, Itakura Y, Ariizumi T, Igarashi M, Kobayashi H, Intaruck K, Kishimoto M, Kobayashi S, Hall W, Sasaki M, Sawa H, Orba Y.”Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain”
    Appl Microbiol Biotechnol., 107(24),7515-7529,(2023 Oct 13)
    DOI: 10.1007/s00253-023-12817-5
12. Kobayashi S, Kawakami R, Takeda C, Maezono K, Thammahakin P, Eguchi H, Hang’ombe MB, Orba Y, Sawa H, Yoshii K, Kariwa H. “Ubiquitin accumulation induced by the finger and palm sub-domains of NS5 modulates the replication of West Nile virus”
    Virology.,588,109902,(2023 Oct 12)
    DOI: 10.1016/j.virol.2023.109902
13. Joseph N, Harima H, Herman C, Sasaki M, Yamagishi J, Annie K, Misheck S, Yongjin Q, Kajihara M, Takada A ,Sawa H, Ngonda S, Edgar S. “Prevalence and Genomic Characterization of Rotavirus A from Domestic Pigs in Zambia: Evidence for Possible Porcine–Human Interspecies Transmission”
    Pathogens,12(10),1199,(2023 Sep 27)
    DOI: 10.3390/pathogens12101199
14. Velu RM, Kwenda G, Bosomprah S, Chisola MN, Simunyandi M, Chisenga CC, Bumbangi FN, Sande NC, Simubali L, Mburu MM, Tembo J, Bates M, Simuunza MC, Chilengi R, Orba Y, Sawa H, Edgar Simulundu. “Ecological Niche Modeling of Aedes and Culex Mosquitoes: A Risk Map for Chikungunya and West Nile Viruses in Zambia”
    Viruses.,15(9),1900,(2023 Sep 8)
    DOI: 10.3390/v15091900
15. Izumi F, Miyamoto S, Masatani T, Sasaki M, Kawakami K, Takahashi T, Fujiwara T, Fujii Y, Okajima m, Nishiyama S, Sawa H, Sugiyama M, Ito N. “Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs.”
    Vaccine.,41(33),4907-4917,89,(2023 Jul 25)
    DOI: 10.1016/j.vaccine.2023.06.076
16. Tamura T, Yamasoba D, Oda Y, Ito J, Kamasaki T, Nao N, Hashimoto R, Fujioka Y, Suzuki R, Wang L, Ito H, Kashima Y, Kimura I, Kishimoto M, Tsuda M, Sawa H, Yoshimatsu K, Yamamoto Y, Nagamoto T, Kanamune J, Suzuki Y, Ohba Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Yokota I, Matsuno K, Takayama K, Tanaka S, Sato K, Fukuhara T. “Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5”
    Commun Biol.,6(1),772,(2023 Jul 24)
    DOI: 10.1038/s42003-023-05081-w
17. Harima H, Qiu Y, Yamagishi J, Kajihara M, Changula K, Okuya K, Isono M, Yamaguchi T, Ogawa H, Nao N, Sasaki M, Simulundu E, Mweene AS, Sawa H, Ishihara K, Hang’ombe BM, Takada A. “Surveillance, Isolation, and Genetic Characterization of Bat Herpesviruses in Zambia”
    Viruses., 15(6),1369,(2023 Jun 13)
    DOI: 10.3390/v15061369
18. Surján A, Gonzalez G, Gellért Á, Boldogh S, Carr MJ, Harrach B, Vidovszky MZ.”First detection and genome analysis of simple nosed bat polyomaviruses in Central Europe”
    Infect Genet Evol.,112,105439,(2023 Jun 13)
    DOI: 10.1016/j.meegid.2023.105439, Epub 2023 Apr 25.
19. Itakura Y, Tabata K, Saito T, Intaruck K, Kawaguchi N, Kishimoto M, Torii S, Kobayashi S, Ito N, Harada M, Inoue S, Maeda K, Takada A , Hall W, Orba Y, Sawa H, Sasaki M. “Morphogenesis of Bullet-Shaped Rabies Virus Particles Regulated by TSG101”
    J Virol.,97(5),e0043823,(2023 May 31),Epub 2023 Apr 12
    DOI: 10.1128/jvi.00438-23
20. Hayashida K, Garcia A, Moonga LC, Sugi T, Kodera T, Kawase M,Kodama F,Nagasaka A, Ishiguro N,Takada A,Kajihara M, Nao N,Shingai M,Kida H,Suzuki Y, Hall W, Sawa H, Yamagishi J. “Field-deployable multiplex detection method of SARS-CoV-2 and influenza virus using loop-mediated isothermal amplification and DNA chromatography”
    PLoS One,18(5),e0285861,(2023 May 16)
    DOI: 10.1371/journal.pone.0285861
21. MacCann R, Leon AAG, Gonzalez G, Carr MJ, Feeney ER, Yousif O, Cotter AG, de Barra E, Sadlier C, Doran P, Mallon PW. “Dysregulated early transcriptional signatures linked to mast cell and
    interferon responses are implicated in COVID-19 severity.”
    Front Immunol.,14,1166574,(2023 May 16)
    DOI: 10.3389/fimmu.2023.1166574